English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Chronic pain associated with rheumatic diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) affects millions of people every year. This pain subsequently affects almost every aspect of a person’s life and has a substantial impact on economics such as health insurance, lost wages, reduced productivity and increased incidence of depression and suicide. These facts highlight the need for relevant disease models to assess new therapies for both inflammation and pain associated with the disease.

biotechniques/biotechniques

Discovery of novel therapies for rheumatic diseases and associated pain requires suitable and relevant disease models: a comparison of monoarthritis and polyarthritis efficacy models.